News

press

Mar 17, 2022

Press Release

Shasqi to Present on SQ3370 and CAPAC platform expansion at the American Association for Cancer Research (AACR) 2022 Annual Meeting

media

Mar 3, 2022

Stanford magazine

Carolyn Bertozzi talks bioorthogonal chemistry in Life is Sweet

press

Jan 7, 2022

Press Release

Shasqi to Present at the 40th Annual J.P. Morgan Healthcare Conference

media

Jan 5, 2022

STAT News

It takes two: The future of click chemistry therapeutics

media

Nov 16, 2021

Macalester Alumni Magazine

Partners with a Purpose

media

Nov 12, 2021

SF Business Times

Peninsula biotech looks to 'click' fresh $50M into new approach against cancer

press

Nov 11, 2021

Press release

Shasqi Raises $50 Million to Expand Click Chemistry Platform Beyond Injectable Tumors and Accelerate Lead Clinical Program

media

Nov 11, 2021

Endpoints News

Investors bet on small biotech's mission

media

Nov 11, 2021

Fierce Biotech

Shasqi snatches $50M Series B

media

Nov 10, 2021

Bioworld

Shasqi poster presentations at ESMO 2021

press

Nov 4, 2021

Press Release

Shasqi to Present Data Updates at Upcoming SITC and CTOS Meetings

conference

Oct 20, 2021

2021 - CTOS - Clinical Poster

First-in-human trial of SQ3370 in relapsed or refractory soft tissue sarcoma and other solid tumors: proof-of-concept for the click chemistry- based CAPAC platform